Christopher DelOrefice's Insider Trades & SAST Disclosures
Christopher DelOrefice's most recent trade in Becton, Dickinson And Co. was a trade of 19,138 Stock Appreciation Rights done . Disclosure was reported to the exchange on Nov. 26, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Christopher DelOrefice.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Becton, Dickinson And Co. | Christopher J. DelOrefice | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 19,138 | 19,138 | - | - | Stock Appreciation Rights | |
| Becton, Dickinson And Co. | Christopher J. DelOrefice | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 9,015 | 26,691 (0%) | 0% | 0 | Common Stock | |
| Becton, Dickinson And Co. | Christopher J. DelOrefice | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2024 | 5,192 | 21,499 (0%) | 0% | 0 | Common Stock | |
| Becton, Dickinson And Co. | Christopher J. DelOrefice | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 4,884 | 17,676 (0%) | 0% | 0 | Common Stock | |
| Resmed Inc. | Christopher DelOrefice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2024 | 1,083 | 1,350 (0%) | 0% | 0 | ResMed Common Stock | |
| Becton, Dickinson And Co. | Christopher DelOrefice | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 07 Sep 2024 | 466 | 12,792 (0%) | 0% | 0 | Common Stock | |
| Resmed Inc. | Christopher DelOrefice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 267 | 267 (0%) | 0% | 0 | ResMed Common Stock | |
| Becton, Dickinson And Co. | Christopher DelOrefice | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Sep 2024 | 254 | 13,258 (0%) | 0% | 0 | Common Stock | |
| Becton, Dickinson And Co. | Christopher DelOrefice | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 18,425 | 18,425 | - | - | Stock Appreciation Rights | |
| Becton, Dickinson And Co. | Christopher DelOrefice | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 3,325 | 14,324 (0%) | 0% | 0 | Common Stock | |
| Becton, Dickinson And Co. | Christopher DelOrefice | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2023 | 812 | 13,512 (0%) | 0% | 0 | Common Stock | |
| Becton, Dickinson And Co. | Christopher DelOrefice | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 07 Sep 2023 | 601 | 10,999 (0%) | 0% | 0 | Common Stock | |
| Becton, Dickinson And Co. | Christopher DelOrefice | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Sep 2023 | 353 | 11,600 (0%) | 0% | 0 | Common Stock | |
| Becton, Dickinson And Co. | Christopher DelOrefice | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 18,658 | 18,658 | - | - | Stock Appreciation Rights | |
| Becton, Dickinson And Co. | Christopher DelOrefice | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 3,087 | 12,222 (0%) | 0% | 0 | Common Stock | |
| Becton, Dickinson And Co. | Christopher DelOrefice | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2022 | 269 | 11,953 (0%) | 0% | 0 | Common Stock | |
| Becton, Dickinson And Co. | Christopher DelOrefice | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 07 Sep 2022 | 506 | 9,135 (0%) | 0% | 0 | Common Stock | |
| Becton, Dickinson And Co. | Christopher DelOrefice | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 2,674 | 9,641 (0%) | 0% | 0 | Common Stock | |
| Becton, Dickinson And Co. | Christopher DelOrefice | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 18,638 | 18,638 | - | - | Stock Appreciation Rights | |
| Becton, Dickinson And Co. | Christopher DelOrefice | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 2,608 | 6,967 (0%) | 0% | 0 | Common Stock | |
| Becton, Dickinson And Co. | Christopher DelOrefice | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Sep 2021 | 4,359 | 4,359 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges